Uncategorized

Covid-19 rebound is probably more common than data suggests, but Paxlovid is still effective

As the coronavirus evolves, the number of treatment options that remain effective against new variants has dwindled. Pfizer's antiviral pill Paxlovid is one of the few that remain. However, some people who take Paxlovid -- and some...

Read more...

Many patients stop taking statins because of muscle pain, but statins aren’t causing it, new study says

Statins are an important tool to prevent major cardiovascular problems, but many patients stop taking them because of side effects, including muscle pain. However, for more than 90% of patients on statins who experience muscle pain,...

Read more...

Atopic dermatitis: FDA approves Dupixent to treat young children

The Food and Drug Administration (FDA) approved Dupixent (dupilumab) to treat atopic dermatitis in children ages 6 months to 5 years old.Dupixent is already approved to treat this skin condition in adults and children ages 6-17.This...

Read more...

Alopecia: FDA approves Olumiant for hair loss treatment

The Food and Drug Administration (FDA) originally approved Olumiant (baricitinib) in 2018 to treat rheumatoid arthritis.The approval of Oluminant reportedly marks the first time the FDA approved a “systemic treatment” for this form of alopecia.Olumiant is available in...

Read more...
en English
X